Buradasınız

ÇOCUKLUK ÇAĞI İDİOPATİK NEFROTİK SENDROMLARINDA RELAPSLARA ETKİ EDEN FAKTÖRLER VE PROGNOZ ÜZERİNE ETKİSİ

THE FACTORS THAT AFFECT THE RELAPSES AND THEIR PROGNOSTIC SIGNIFICANCE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Retrospective analysis of 113 children with idio-pathic nephrotic syndrome (INS) was performed bet¬ween January 1990 and January 1995. The mean age of the patients was 3.9 years and male/female ratio was 1.3. All the patients had edema at first admission while 60 had infection. Steroid therapy was started on 109 patients. One hundred and two patients had re¬mission while 7 (6.4 %) patients did not respond. At least one relaps developed in 46.9 % of patients and most of the first relapses occured within the first year. Occurence of relapses was found to be more frequent in the patients who received albumin infusion. Num¬ber of relapses in the patients whose follow up period is more than two years were higher in male patients and whose initiation of the disease is after 3 years of age. Thirty four percentage of the relapses were associated with infection. Two patients died because ofin-fection (1.8 %). Fifteen patients had spontaneous re¬mission in different stages of the disease and 8 pati¬ents (7.1 %) developed frequent relapses. Fifteen pati¬ents with frequent relapses or steroid dependent and steroid resistant nephrotic syndrome were given cyclophosphamide therapy and 3 nonresponders were administered chlorambucil with a good result. In this study we showed once more that INS is frequent in childhood, infection is an important factor that affect the mortality and morbidity of the disease, relapses are more frequent in males and in patients whose di¬sease onset is after 3 years of age and with appropria¬te therapy its mortality is low with a good prognosis
Abstract (Original Language): 
Ocak 1990 ile Ocak 1995 tarihleri arasında idio-patik nefrotik sendrom (İNS) tanısı alan 113 çocuk retrospektif olarak incelendi. Vakalarının yaş ortala¬ması 3.9, erkek/kız oranı ise 1.3 idi. Hastaların hep¬sinde ilk başvuruda ödem mevcut olup 60 (% 53.1) vakada enfeksiyon tesbit edildi. Steroid tedavisi başlanan 109 hastanın 102'si remisyona girdi, 7 hasta (% 6.4) ise tedaviye cevap vermedi. Hastaların % 46.9'unda en az bir kere relaps gözlendi ve ilk relaps-lar en sık ilk bir yıl içinde gelişti. Albumin infüzyonu yapılan hastalarda relaps oranı daha yüksek bulunur¬ken, izlem süreleri iki yılın üzerinde olan 64 hastada relapsların erkeklerde ve üç yaş üzerinde hastalık başlayanlarda daha sık olduğu gözlendi. Relapsların % 34.4'ü enfeksiyon ile ilişkili bulundu. İki hasta en¬feksiyon nedeniyle kaybedildi (% 1.8). On beş hasta değişik dönemlerde spontan remisyona girdi. Sekiz hastada (% 7.1) ise sık relaps gözlendi. Steroide ba¬ğımlı, sterolde dirençli ve sık relaps gösteren toplam 15 İNS'lu vakaya oral siklofosfamid tedavisi uygulan¬dı. Siklofosfamide cevap vermeyen üç hastada ise klo-rambusil tedavisi ile remisyon sağlandı. Sonuç olarak bu çalışma ile İNS'un çocukluk yaş grubunda sık gö¬rüldüğü, enfeksiyonların hastalığın mortalite ve mor-bitesini etkileyen önemli bir faktör olduğu, erkeklerde ve üç yaş üzerindeki hastalık başlayanlarda relaps riskinin daha fazla olduğu, uygun tedavi ile mortalite oranının düşük, prognozun iyi olduğu gösterildi.
FULL TEXT (PDF): 
80-85

REFERENCES

References: 

1. Nash MA, Edelmann CM, Bernstein J, Barnett HL. The Nephrotic Syndrome Pediatric Kidney Disease (2nd ed) (Vol II), edited by Edelmann CM (ed), Little Brown and Co, Boston 1992, pp 1247-1266.
2. Kelsch RC, Sedman AB. Nephrotic syndrome. Pediatric in Review 1993; 1:30-38.
3. Nash MA, Edelmann CM, Bernstein J, Barnett HL. Mi¬nimal Change Nephrotic Syndrome, Diffuse Mesangial Hypercellularity and Focal Glomerular Sclerosis in Pe-diatric Kidney Disease (2nd ed) (Vol II), In: Edelmann
CM (ed), Boston, Little Brown and Co, 1992, pp 1267¬1290.
4. Cameron JS. The nephrotic syndrome and its complica¬tions. Am J Kid Dis 1987; 10: 157-171.
5. Bernard DB. Extrarenal complications of the nephrotic
syndrome. Kidney Int 1988; 33: 1184-1202.
6. Melvin T, Bennett W. Management of nephrotic syndro¬me in childhood. Drugs 1991; 42: 30-51.
7. Davison AM. Steroid therapy in primary glomerulo-
nephritis. Nephrol Dial Transplant (Suppl.) 1990; 1: 23¬28.
8. Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 1993;91:1142-1146.
9. Yoshimura A, Ideura T, Iwasaki S, Taira T, Koshikawa S. Aggravation of minimal changes nephrotic syndrome by administration of human albumin. Clin Nephrol 1992;37:109-114.
10. Mallick NP. Epidemiology and natural course of idio-pathic nephrotic syndrome. Clin Nephrol 35 (Suppl.)
1991; 1: 53-57.
11. Ehrich JHH, Brodehl J. Long versus standard predniso-ne therapy for initrial treatment of idiopathic nephrotic syndrome in children. Eur J Pediatr 1993; 152: 357-361.
12. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98: 561-564.
13. Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarte HJ. Predicting the response to the cytotoxic therapy for childhood nephrotic syndrome: Superiority of response to corticosteroid therapy over histopatholo-
gic patterns. J Pediatr 1988; 113: 996-1001.
14. Krensky AM, Ingelfinger JR, Grupe WE. Peritonitis in childhood nephrotic syndrome. Am J Dis Child 1982; 136: 732-736.
15. Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 35 (Suppl.) 1991; 1:
8-15.
16. Trompeter RS. Immunosuppressive therapy in the neph-rotic syndrome in children. Pediatr Nephrol 1989; 3: 194-200.
17. Srivastava RN, Vasudev AS, Bligga A, Sunderam KR. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 1992; 6: 247-250.
18. Niaudet P, Broyer M, Habib R. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin
Nephrol 35 (Suppl.) 1991; 1: 31-36.
19. Lewis MA, Baildom EM, Davis N, Houston IB, Post-lethwaite RJ. Nephrotic syndrome: From toddlers to
twenties. Lancet 1989; 4: 255-259.
20. Trompeter RS, Lloyd BW, White RHR, Hicks J, Came¬ron JS. Long-term outcome for children with minimal change nephrotic syndrome. Lancet 1985; 1: 368-370.

Thank you for copying data from http://www.arastirmax.com